Blue Yonder Empowers Retailers to Drive Personalized, Omni-Channel Commerce Experiences
Focused on empowering retailers to meet and exceed the rapidly evolving consumer expectations around fulfillment speed, convenience and accuracy, and to reduce the cost to fulfill, Blue Yonder has launched several microservices under the Luminate™ Commerce portfolio to help retailers meet the demands of consumers. These individually deployable, augmentative microservices offer a reimagined and personalized consumer experience by allowing retailers to ensure order and fulfillment accuracy.
E-commerce was rapidly growing prior to 2020; however, the COVID-19 pandemic pushed even more consumers online, contributing an additional $105 billion in U.S. online revenue in 2020 and accelerating e-commerce by two years, as reported in Digital Commerce 360. In addition, nearly $1 in every $5 spent on retail purchases continue to come from digital orders, according an analysis of Commerce Department Q2 2021 data.
“The traditional monolithic solutions are very limiting to retailers and don’t give them the ability to add new features. Our microservices allow retailers to augmentatively add new capabilities without the need to rip and replace their existing solutions. This allows them to realize the value of the new capabilities quickly and meet business goals. As a result, many of our customers start with one microservice and after seeing benefits, they come back to us to implement additional services to help them meet customer demands while also keeping an eye on their bottom line,” said Eugene Amigud, corporate vice president, Product Management and Architecture, Blue Yonder.
Whether curbside pickup, buy online pickup in store (BOPIS), shipped from/to store, or same-day delivery/last-mile, retailers need omni-channel solutions to help them digitally transform to meet e-commerce growth. That’s why Blue Yonder has launched an end-to-end suite of highly scalable and individually deployable digital commerce microservices that include:
- Commits : Retailers can provide accurate, aggressive, and cost-effective promised delivery dates, and flexible fulfillment options early in the buying process to increase conversion rates, as well as optimize fulfillment to save costs. It enables retailers to deliver the right product, at the right time, through the consumers’ channel of choice, with the speed and convenience that consumers expect.
- Inventory Availability : Everyone needs to know where inventory is located and how it can be used. Retailers can present shoppers with enterprise-wide, real-time inventory availability data to incent them to buy. Retailers can show shoppers what’s available at their local store versus available for shipping and incent them to buy with urgency messaging (for example, one item left). Consumers can also easily reserve and then later buy products.
- Order Fulfillment : Retailers can perform store micro-fulfillment activities, i.e., pick, pack and fulfill orders, with increased accuracy and improved productivity. Store associates can serve customers thru various methods such as curbside delivery, deliver at home, delivery in-store, or ship to home. Store associates and managers have complete visibility of all store micro-fulfillment activities with actionable dashboards.
- Order Services and Customer Order Visibility (COV) – This high-performing, scalable API-based microservice orchestrates and manages the entire order-to-cash lifecycle. It provides a centralized view of orders, whether they are placed from a retailer’s website, a physical store, an online marketplace or a call center — and across brands and geographies. Customer Order Visibility (COV) is a real-time tracking and monitoring solution with an intuitive user experience that enables customer service, retail and other staff to search, view and modify real-time order details in one place, creating a single, up-to-date repository of order information. The COV uses an integrated user interface so businesses can search, view and modify order details in one place, with complete visibility into each order and its fulfillment details. Leveraging unsupervised learning algorithms, COV generates actionable insights on metrics that organizations can use to optimize the promising and fulfillment process.
Powered by machine learning analytics, these microservices can quickly detect anomalies with minimal or no manual configuration and draw attention to areas of potential need, including stock out predictions, sell through rates, the need for markdowns, and inventory accuracy.
“Our microservices enable retailers to leverage stores in their digital transformation journey while continuing to manage existing day-to-day operations. Retailers can now empower today’s shoppers to make smarter decisions, increasing customer satisfaction while streamlining store fulfillment operations and increasing productivity and revenue,” said Omar Akilah, corporate vice president – Commerce, Blue Yonder.
- Learn more about how Blue Yonder’s new microservices provide a personalized commerce experience
- At NRF 2022 Retail’s Big Show in New York City, join the “Smarter customer connections at Petco and Sally Beauty produced by Blue Yonder” Big Ideas session on Jan. 17, 2022, 10:15 a.m. ET
- Learn more about Blue Yonder’s Luminate Commerce portfolio
- Learn more about intelligent order promising
- Watch the “Journey of the Yoga Pants with Luminate Commerce” video
About Blue Yonder
Blue Yonder is the world leader in digital supply chain and omni-channel commerce fulfillment. Our intelligent, end-to-end platform enables retailers, manufacturers and logistics providers to seamlessly predict, pivot and fulfill customer demand. With Blue Yonder, you can make more automated, profitable business decisions that deliver greater growth and re-imagined customer experiences. Blue Yonder - Fulfill your Potential™ blueyonder.com
“Blue Yonder” is a trademark or registered trademark of Blue Yonder Group, Inc. Any trade, product or service name referenced in this document using the name “Blue Yonder” is a trademark and/or property of Blue Yonder Group, Inc. All other company and product names may be trademarks, registered trademarks or service marks of the companies with which they are associated.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Blue Yonder Public Relations Contacts:
Marina Renneke, APR, Corporate Communications Manager
Tel: +1 480-308-3037, email@example.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LabGenius Appoints Dr. Gino Van Heeke as Chief Scientific Officer30.11.2021 03:00:00 EET | Press release
LabGenius, the machine learning (ML)-driven protein engineering company, today announced the appointment of Gino Van Heeke Ph.D. as Chief Scientific Officer (CSO). In this role, Gino will leverage his wealth of drug discovery and development experience to direct LabGenius’ scientific strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211129005436/en/ Dr. Gino Van Heeke Appointed as LabGenius' CSO (Photo: Business Wire) “I’m extremely pleased to welcome Gino to the company as CSO,” said Dr. James Field, Founder and CEO of LabGenius. “Gino is an accomplished scientific leader with an impressive track record of successfully advancing drug candidates into pre-clinical and clinical development.” Gino joins LabGenius from Engitix Therapeutics, where, as CSO, he established a portfolio of projects and initiated the company’s first drug discovery campaign. Before this, Gino was Senior Director, Discovery and Early Development
InVeris Training Solutions Unveils SRCE™ – a Revolutionary, Augmented Reality Training System29.11.2021 22:00:00 EET | Press release
InVeris Training Solutions, the leading provider of integrated live-fire and virtual weapons training systems for military, law enforcement agencies and commercial shooting ranges, today unveils SRCE™ (See, Rehearse, Collectively Experience or "Source"), a groundbreaking, augmented reality-based, untethered weapons training simulator. InVeris Training Solutions provides the most advanced augmented reality technology available in a military and law enforcement training simulator, a feat previously thought to be years away by many in the industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211129005628/en/ SRCE is the only untethered AR training solution on the market—allowing up to 4 participants to train with simulated weapons and tactical gear. (Photo: Business Wire) "Augmented reality delivers the best of the virtual and real worlds in a way that's fully lifelike, seamless, customizable and economical," said InVeris CE
Verimatrix Launches Streamkeeper To Offer Industry’s First Battle-Ready Cybersecurity Solution Engineered to Hunt Down and Take Out Video Piracy29.11.2021 19:45:00 EET | Press release
Regulatory News: Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced the launch of its new Verimatrix StreamkeeperSM solution, a cybersecurity and anti-piracy gamechanger for the media & entertainment industry. Streamkeeper empowers customers to hunt down and take out OTT pirates who steal content such as live sports and premium movie as they are distributed from the source to the endpoint (mobile app/user level). The solution includes Verimatrix's all-new CounterspySM technology -- the autonomous injection of an anti-piracy and app protection security agent that utilizes the company’s proprietary zero code technology which allows customers to add deep, defensive countermeasures, plus monitor their clients without the hassle of a huge integration effort. Integration efforts have also been reduced dramatically, from months to minutes, accompanying numerous operator benefits ranging from a reducti
Introducing ThreatConnect 6.4 - Improving Threat Intelligence Processes and SOC Metrics29.11.2021 19:31:00 EET | Press release
ThreatConnect Inc.®, the leader in enabling a risk led and intelligence-driven security is announcing ThreatConnect 6.4, which introduces new capabilities that allow security operations and cyber threat intelligence (CTI) analysts to get useful context faster during investigations and to better measure team efficiencies. ThreatConnect combines its Threat Intelligence Platform (TIP) and Security Orchestration and Automation platform (SOAR), creating a continuous feedback loop that helps make Intelligence-Driven Operations a reality. This latest product release builds upon the foundation of Intelligence-Driven Operations, empowering the workflow of threat intelligence and security operations teams individually and together. The 6.4 release helps CTI and security operations center (SOC) teams get more context quickly, enabling faster investigations for both. CTI teams are enabled to more easily build and maintain a dynamic threat library, while updated dashboards allow SOC and IR leaders
ESI Group Unveils Its New Leadership Team29.11.2021 19:00:00 EET | Press release
Regulatory News: ESI Group (ISIN Code: FR0004110310, Symbol: ESI) (Paris:ESI) announces today the completion of its new leadership team from seasoned professionals from the current organization and the appointment of Ajit Gokhale as Executive Vice-president Engineering. Cristel de Rouvray, Chief Executive Officer of ESI Group says: "With the release of our “OneESI 2024 – Focus to Grow” plan two months ago, we are engaged in a profound transformation. To lead our Group and this transformational effort, I can count on the full support of my new Leadership Team which is composed of nine impressive, complementary and highly experienced individuals. I’m also proud to welcome in our team Ajit Gokhale who will play a key role in our organization and more specifically in our software engineering strategy and execution. Together, we are entirely committed to bring our company to the next level and to transform it as one of the key leading software partners for industry.” Creation of a new leade
Gilead and AWS Collaborate on Development and Delivery of New Medicines for Patients29.11.2021 17:00:00 EET | Press release
Today, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), announced that Gilead Sciences, Inc. (Nasdaq: GILD), a biopharmaceutical company advancing innovative medicines to prevent and treat life-threatening diseases, has selected AWS as its preferred cloud provider. Innovating on AWS and with the help of AWS experts and partners in healthcare and life sciences, Gilead provides its data scientists with the latest advances in machine learning and analytics. These capabilities fuel data-driven decision making across the organization—from biomarker discovery through manufacturing and clinical trial recruitment—and deliver insights that can help Gilead refine its drug pipeline. The company also relies on AWS to host all workloads for its enterprise resource planning (ERP) transformation project to implement SAP S/4HANA. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211129005047/en/ “With AWS as our pre
Celltrion accelerates development of nebulised cocktail therapy (CT-P63 in combination with CT-P59) using its antibody platform to tackle new COVID-19 variants29.11.2021 16:08:00 EET | Press release
Celltrion Group announced today that the company has accelerated development of a nebulised formulation of its neutralising antibody cocktail treatment, to respond to emerging mutants from SARS-CoV-2. Targeting newly emerging mutations of SARS-CoV-2 and using its already constructed antibody platform, Celltrion has developed a neutralising antibody cocktail consisting of CT-P63 together with its monoclonal antibody treatment Regkirona (regdanvimab, CT-P59), which was recently approved by the European Commission (EC) for the treatment of COVID-19. Celltrion enrolled 24 healthy volunteers in its global phase I clinical trial to evaluate the safety, tolerability and pharmacokinetics of CT-P63 and the company anticipates results by the end of the year. CT-P63 is a monoclonal antibody targeting SARS-CoV-2 spike receptor binding domain (RBD) as a treatment for COVID-19 infection. Celltrion plans to evaluate neutralisation of new emerging variants tailored to specific regions and assess poten
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom